| View |
|
DRP-9391-06
|
Telmisartan
|
Cormed 80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics Private Limited
|
India
|
CLIDP Conversion
|
22 November 2022
|
02 March 2026
|
| View |
|
DRP-10323-03
|
Etoricoxib
|
Maricoxia-90
|
90 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory and Antirheumatic
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
22 November 2022
|
10 September 2026
|
| View |
|
DRP-12155-01
|
Atorvastatin (as Calcium Trihydrate)
|
Genvazt-20
|
20mg
|
Film-Coated Tablet
|
HMG CoA Reductase inhibitor
|
ACME Formulations Pvt. Ltd
|
India
|
CLIDP Conversion
|
22 November 2022
|
22 June 2027
|
| View |
|
DRP-12328-01
|
Metformin hydrochloride + Sitagliptin (as phosphate)
|
Sitaphil Plus
|
1 g/ 50 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
22 November 2022
|
15 July 2027
|
| View |
|
DRP-2433-04
|
Clindamycin (as hydrochloride)
|
None
|
300 mg
|
Capsule
|
-
|
New Myrex Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
22 November 2022
|
03 September 2025
|
| View |
|
DRP-5579-02
|
Phenytoin Sodium
|
One-Dextin
|
100 mg
|
Capsule
|
Anticonvulsant/Anti-epileptic
|
Swiss Pharma Private Limited
|
India
|
Renewal
|
30 January 2023
|
28 January 2028
|
| View |
|
DRP-7138-17
|
Ceftriaxone (as sodium)
|
Protriaxone
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Zeiss Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 November 2022
|
31 March 2027
|
| View |
|
DRP-8403-07
|
Cefuroxime (as Sodium)
|
Biozef
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Second Generation Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
28 November 2023
|
15 February 2028
|
| View |
|
DRP-9107-01
|
Fusidic acid + Betamethasone (as valerate)
|
Fuziem-B
|
20 mg/1 mg per gram (2%/0.1% w/w)
|
Cream
|
-
|
Encube Ethicals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
21 November 2022
|
10 September 2025
|
| View |
|
DRP-10165-01
|
Oxaliplatin
|
Oxaliget
|
2 mg/mL (100 mg/50 mL)
|
Concentrate Solution for IV Infusion
|
-
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
21 November 2022
|
06 October 2026
|
| View |
|
DRP-10592-01
|
Paclitaxel
|
Clitax
|
6 mg/mL
|
Solution for I.V. Infusion
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
21 November 2022
|
26 October 2026
|
| View |
|
DRP-10626-01
|
Rocuronium Bromide
|
Rocugen
|
10 mg/mL
|
Solution for Injection (IV)
|
-
|
Immacule Lifesciences Private Limited
|
India
|
CLIDP Conversion
|
21 November 2022
|
03 November 2026
|
| View |
|
DRP-11805-02
|
Co-Amoxiclav
|
Clavugen
|
625 mg
|
Film-Coated Tablet
|
-
|
Yeluri Formulations Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 November 2022
|
05 May 2027
|
| View |
|
DRP-12583-01
|
Omeprazole (as Sodium)
|
Terracid
|
40 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Proton Pump Inhibitor
|
Reyoung Pharmaeutical Co., Ltd
|
China
|
CLIDP Conversion
|
21 November 2022
|
08 September 2027
|
| View |
|
DRP-5683-18
|
CEFIXIME
|
TRUQUEST
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
J.M. Tolmann Laboratories , Inc.
|
Philippines
|
Renewal
|
19 December 2023
|
20 February 2029
|
| View |
|
DRP-6051-19
|
Ketoanalogues + Essential Amino Acids
|
Pharmalogue
|
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
04 August 2024
|
13 March 2030
|
| View |
|
DRP-6383-02
|
Sitagliptin (as phosphate monohydrate)
|
Sitajack
|
50 mg
|
Film-Coated Tablet
|
Oral hypoglycemic
|
Bafna Pharmaceutical Limited
|
India
|
CLIDP Conversion
|
19 November 2022
|
09 October 2025
|
| View |
|
DRP-6942-03
|
Multivitamins + Iron
|
Mediron
|
Thiamine Hydrochloride (Vitamin B1) 2 mg, Riboflavin (Vitamin B2) 2 mg, Pyridoxine Hydrochloride (Vitamin B6) 2 mg, Folic Acid 400 mcg
Cyanocobalamin (Vitamin B12) 10 mcg, Iron (as Ferrous Sulfate) 65 mg (eq. to 200 mg Ferrous Sulfate)
|
Capsule
|
Vitamins and Mineral
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
19 November 2022
|
13 December 2026
|
| View |
|
DRP-8055-04
|
Carvedilol
|
Retadilol
|
6.25 mg
|
Tablet
|
-
|
Akriti Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 November 2022
|
27 March 2027
|
| View |
|
DRP-8237-02
|
Tamsulosin Hydrochloride
|
Tamzor
|
400 mcg
|
Prolonged-Release Capsule
|
Alpha-adrenoreceptor antagonists
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
02 February 2024
|
18 June 2029
|